Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments von Ding, Jennifer, Karp, Judith E, Emadi, Ashkan

Volltext

Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia von Zeidner, Joshua F, Karp, Judith E

Volltext

Systematic review and meta‐analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia von Franco, Stephanie, Geng, Xue, Korostyshevskiy, Valeriy, Karp, Judith E., Lai, Catherine

Volltext

Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome von Williams, Lacey, Doucette, Kimberley, Karp, Judith E., Lai, Catherine

Volltext

Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? von Estey, Elihu, Karp, Judith E., Emadi, Ashkan, Othus, Megan, Gale, Robert Peter

Volltext

Lessons from tumor reversion for cancer treatment von Amson, Robert, Karp, Judith E, Telerman, Adam

Volltext

Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials von Frankel, Paul H, Groshen, Susan, Beumer, Jan H, Cleveland, Laura, Kim, Edward S, Karp, Judith E

Volltext

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience von Wolff, Antonio C, Blackford, Amanda L, Visvanathan, Kala, Rugo, Hope S, Moy, Beverly, Goldstein, Lori J, Stockerl-Goldstein, Keith, Neumayer, Leigh, Langbaum, Terry S, Theriault, Richard L, Hughes, Melissa E, Weeks, Jane C, Karp, Judith E

Volltext

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine von Gojo, Ivana, Karp, Judith E

Volltext

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia von Ramos, Nestor R, Mo, Clifton C, Karp, Judith E, Hourigan, Christopher S

Volltext

Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells von Dai, Haiming, Ding, Husheng, Meng, X Wei, Peterson, Kevin L, Schneider, Paula A, Karp, Judith E, Kaufmann, Scott H

Volltext

Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs von Emadi, Ashkan, Karp, Judith E

Volltext

Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy von Knaus, Hanna A, Berglund, Sofia, Hackl, Hubert, Blackford, Amanda L, Zeidner, Joshua F, Montiel-Esparza, Raúl, Mukhopadhyay, Rupkatha, Vanura, Katrina, Blazar, Bruce R, Karp, Judith E, Luznik, Leo, Gojo, Ivana

Volltext

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication? von Cook, Michael R., Karp, Judith E., Lai, Catherine

Volltext

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms von GORE, Steven D, BAYLIN, Stephen, RUDEK, Michelle A, MING ZHAO, SMITH, B. Douglas, MANNING, Jasper, JIEMJIT, Anchalee, DOVER, George, MAYS, Abbie, ZWIEBEL, James, MURGO, Anthony, WENG, Li-Jun, SUGAR, Elizabeth, HERMAN, James G, CARRAWAY, Hetty, MILLER, Carole B, CARDUCCI, Michael, GREVER, Michael, GALM, Oliver, DAUSES, Tianna, KARP, Judith E

Volltext

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification von Hochman, Michael J., Othus, Megan, Hasserjian, Robert P., Ambinder, Alex, Brunner, Andrew, Percival, Mary-Elizabeth M., Hourigan, Christopher S., Swords, Ronan, DeZern, Amy E., Estey, Elihu H., Karp, Judith E.

Volltext

BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma von Correia, Cristina, Schneider, Paula A., Dai, Haiming, Dogan, Ahmet, Maurer, Matthew J., Church, Amy K., Novak, Anne J., Feldman, Andrew L., Wu, Xiaosheng, Ding, Husheng, Meng, X. Wei, Cerhan, James R., Slager, Susan L., Macon, William R., Habermann, Thomas M., Karp, Judith E., Gore, Steven D., Kay, Neil E., Jelinek, Diane F., Witzig, Thomas E., Nowakowski, Grzegorz S., Kaufmann, Scott H.

Volltext

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome von Crispino, John D, Wechsler, Joshua, Greene, Marianne, McDevitt, Michael A, Anastasi, John, Karp, Judith E, Le Beau, Michelle M

Volltext

When the Minimal Becomes Measurable von Hourigan, Christopher S, Goswami, Meghali, Battiwalla, Minoo, Barrett, Austin J, Sheela, Sheenu, Karp, Judith E, Lai, Catherine

Volltext

A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response von Pratz, Keith W., Cortes, Jorge, Roboz, Gail J., Rao, Niranjan, Arowojolu, Omotayo, Stine, Adam, Shiotsu, Yukimasa, Shudo, Aiko, Akinaga, Shiro, Small, Donald, Karp, Judith E., Levis, Mark

Volltext